Clinical trials of the AstraZeneca vaccine are still in progress.
Copyright 2020 The Associated Press. All Rights Reserved
Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”. It is the first time that a drugmaker has presented a coronavirus vaccine for approval in Switzerland.
AstraZeneca, which developed the vaccine in collaboration with the University of Oxford, submitted its application to Swissmedic at the start of this month.
The vaccine’s scientific evaluation will be done via a “rolling submission” process. This allows a pharmaceutical company to launch the application procedure before a product’s development is complete.
This “enables Swissmedic to carry out the scientific assessment of non-clinical data from laboratory tests while clinical trials are still in progress,” announced Swissmedic in a statement on Tuesday, noting that trial results must be submitted for scientific review as they become available over the next weeks and months.
More
More
Half of Swiss would get vaccinated against Covid-19
This content was published on
If there were an efficient vaccination against coronavirus, every second person in Switzerland would take it, says a survey.
“However, no decision on authorisation can be taken until all the data needed to assess the safety, quality and efficacy of the vaccine have been submitted. The documentation must demonstrate how safe and effective the vaccine is in protecting humans against the new SARS-CoV-2 coronavirus,” wrote the Swiss drug authority.
Swissmedic noted that while it is reviewing the vaccine independently, it is also working closely with partner authorities abroad. No medicinal product can go onto the Swiss market without Swissmedic’s approval.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Personal care products affect indoor air quality, warns Swiss study
This content was published on
A Swiss study claims that typical personal care products can have a ‘significant impact’ on air quality when used in enclosed spaces.
Government estimates for first time Switzerland’s carbon budget up to 2050
This content was published on
The Swiss government predicts that the country will produce around 660 million tonnes of CO2 equivalents for the 2020-2050 period if it meets its climate targets.
Switzerland imposes entry ban on far-right Austrian activist Martin Sellner
This content was published on
Switzerland has imposed an entry ban on the far-right Austrian extremist Martin Sellner. This prevents him from speaking at an event planned by the Swiss Junge Tat far-right group in canton Zurich.
Security firm Sicpa cuts jobs in western Switzerland
This content was published on
Sicpa, a company specialising in security inks, announced on Thursday that it plans to cut up to 120 jobs in canton Vaud, citing a complicated international economic context and geopolitical tensions.
UK resumes trade talks with Switzerland in ‘Global Britain’ push
This content was published on
British and Swiss trade negotiators will resume trade talks on Monday as they seek to broker deeper access to each other’s financial services markets as well as agreements on data sharing and worker visas.
Swiss army suspends CHF320m project for airspace surveillance
This content was published on
The Swiss parliament approved almost CHF320 million for "Skyview" airspace surveillance system. The reason for the suspension is problems with the integration of the system.
Murdered student: Paris asks Bern to extradite suspect
This content was published on
On Wednesday, France submitted an extradition request to the Swiss authorities for the man suspected of murdering Philippine. This was announced Thursday morning by the French Minister of Justice, Didier Migaud, on BFMTV.
Switzerland pre-orders 4.5 million doses of Covid-19 vaccine
This content was published on
The Swiss government has signed a deal with US biotech firm Moderna to secure early access to 4.5 million doses of a Covid-19 vaccine currently in development.
Switzerland fast-tracks antiviral medication against Covid-19
This content was published on
Swissmedic, the agency that oversees the use of medicaments in Switzerland, took days to fast-track approval of the drug, which is produced under the brand name Veklury by US biopharmaceutical company Gilead Sciences. The application for its extended use was only received on Monday. It can now be used for a limited period of time to…
Join the conversation!